Home › Metastatic Cancer › North Carolina › Charlotte
Pag-aaral pangklinika para sa Metastatic Cancer sa Charlotte, NC
Isang pag-aaral para sa Metastatic Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Charlotte. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Nagre-recruitPhase 1/2
- Levine Children's Hospital- Pediatric Neuro-Oncology, Charlotte
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Nagre-recruitPhase 2/3
- Levine Cancer Institute, Charlotte
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Nagre-recruitPhase 1/2
- Atrium Health Levine Cancer Institute, Charlotte
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Nagre-recruitPhase 3
- Levine Cancer Institute, Charlotte
- Oncology Specialists of Charlotte, Charlotte
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Nagre-recruitPhase 1/2
- Carolina Biooncology Institute, Huntersville · 13 mi ang layo
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Carolina Biooncology Institute, Huntersville · 13 mi ang layo
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
Nagre-recruitPhase 1/2
- Levine Cancer Institute, Charlotte
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Nagre-recruitPhase 1
- Carolina BioOncology Institute, Huntersville · 13 mi ang layo
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
Nagre-recruitPhase 1/2
- Carolina BioOncology Institute, Huntersville · 13 mi ang layo
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Nagre-recruitPhase 1/2
- Levine Cancer Institute (LCI)- Atrium Health, Charlotte
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Carolina BioOncology Institute, Huntersville · 13 mi ang layo
Pag-aaral para sa Metastatic Cancer sa ibang lungsod
- Houston, TX104 pag-aaral
- New York City, NY93 pag-aaral
- Nashville, TN70 pag-aaral
- Boston, MA63 pag-aaral
- Los Angeles, CA57 pag-aaral
- St. Louis, MO54 pag-aaral
- Arlington, VA53 pag-aaral
- Philadelphia, PA46 pag-aaral
- Chicago, IL45 pag-aaral
- San Antonio, TX44 pag-aaral
- Washington, DC43 pag-aaral
- Dallas, TX42 pag-aaral
Iba pang pag-aaral sa Charlotte
- Kanser (lahat ng uri)27 pag-aaral
- Kanser sa Suso22 pag-aaral
- Multiple Myeloma21 pag-aaral
- Non-Small Cell Lung Cancer19 pag-aaral
- Acute Myeloid Leukemia16 pag-aaral
- Obesity16 pag-aaral
- Overweight15 pag-aaral
- Colorectal Cancer13 pag-aaral
- Kanser sa Ovary12 pag-aaral
- Pagkabigo ng Puso11 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg10 pag-aaral
- COPD9 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.